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Biochemomechanics
of Intraluminal Thrombus
in Abdominal Aortic Aneurysms
Most computational models of abdominal aortic aneurysms address either the hemody-
namics within the lesion or the mechanics of the wall. More recently, however, some
models have appropriately begun to account for the evolving mechanics of the wall in
response to the changing hemodynamic loads. Collectively, this large body of work has
provided tremendous insight into this life-threatening condition and has provided impor-
tant guidance for current research. Nevertheless, there has yet to be a comprehensive
model that addresses the mechanobiology, biochemistry, and biomechanics of thrombus-
laden abdominal aortic aneurysms. That is, there is a pressing need to include effects of
the hemodynamics on both the development of the nearly ubiquitous intraluminal throm-
bus and the evolving mechanics of the wall, which depends in part on biochemical effects
of the adjacent thrombus. Indeed, there is increasing evidence that intraluminal thrombus
in abdominal aortic aneurysms is biologically active and should not be treated as homo-
geneous inert material. In this review paper, we bring together diverse findings from the
literature to encourage next generation models that account for the biochemomechanics
of growth and remodeling in patient-specific, thrombus-laden abdominal aortic aneur-
ysms. [DOI: 10.1115/1.4023437]
Keywords: aorta, hemodynamics, stress analysis, biomechanics, inflammation, proteases,
growth and remodeling
1 Introduction
Abdominal aortic aneurysms (AAAs) are focal dilatations of
the infrarenal aorta; they tend to enlarge over years but rupture
abruptly when wall stress exceeds wall strength. These lesions are
prevalent in the aging population and, consequently, are increas-
ingly responsible for morbidity and mortality. Although the patho-
genesis is still not well understood, there is a wealth of biological,
clinical, histopathological, and mechanical data on AAAs, and
there has been significant progress in the biomechanical modeling
of these lesions [1,2]. Nevertheless, our ability to predict whether
a specific lesion will arrest, continue to enlarge either slowly or
rapidly, or ultimately rupture remains wanting. Clinical interven-
tions thus continue to be based primarily on the maximum dimen-
sion or expansion rate of the lesion as well as symptoms (e.g.,
pain) despite the observation that many small lesions rupture
whereas larger lesions may remain asymptomatic [3]. There is
clearly a need for increased understanding.
One possible reason for this variability in clinical outcomes that
has garnered increased attention is the intraluminal thrombus
(ILT). The majority of AAAs harbor an ILT, which may vary in
thickness from a few millimeters to multiple centimeters. These
thrombi have complex natural histories and structures, and their
biological and mechanical roles in the progression and potential
rupture of AAAs remains controversial. The goals of this paper,
therefore, are twofold. First, we review salient aspects of the de-
velopment and progression of ILT, its evolving mechanical prop-
erties, and its potential role in the biochemomechanics that govern
the natural history of AAAs. Second, we discuss past successes
and future needs regarding mathematical modeling of the role of
ILT in AAA progression, both from a classical mechanical and a
contemporary growth and remodeling (G&R) perspective. Toward
this end, we submit that an increased ability to understand and
quantify the evolving heterogeneous biochemomechanical proper-
ties of ILT and its effects on the natural history of the aneurysmal
wall will not only help resolve controversies that have arisen from
past consideration of the ILT as a homogeneous and/or inert struc-
ture, it will also guide future clinically motivated experimental
and computational efforts to understand, predict, and therapeuti-
cally address the roles of ILT in this challenging and important
vascular pathology.
2 Hemodynamics and ILT Development
The disturbed hemodynamics that characterizes blood flow in
AAAs likely plays a major role in initiating and sustaining the
cascade of processes that promote ILT. Several experimental and
computational studies of blood flow in idealized and patient-
specific models of AAAs suggest that particular characteristics
might be recurrent [4–8]. For example, vortical structures may de-
velop during systole and then propagate and dissipate during dias-
tole [8–10]. The outer regions of these vortices, in turn, may allow
regions of high fluid shear stress that can exist away from the arte-
rial wall. At the aneurysmal wall, however, shear stress has been
consistently reported to be lower compared with values typically
computed on the endothelium of the healthy aorta [5,7,8]. Thus,
the hemodynamic environment in nascent AAAs may simultane-
ously contain regions favorable to platelet activation (due to high
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shear stresses in the lumen where platelets activate) and adhesion
(due to low wall shear stresses where platelets may aggregate on a
vulnerable endothelium).
Note, therefore, that early thrombus development is character-
ized by aggregation of activated platelets and entrapment of eryth-
rocytes and a small number of leukocytes within an evolving
fibrin mesh; this fibrin accumulates as activated thrombin cleaves
fibrinogen into fibrin, which then polymerizes to form the under-
lying mesh. Fibrin is stabilized via crosslinking by activated factor
XIII (i.e., fXIIIa). Primary thick fibrin fibers may form around the
initially plentiful erythrocytes, but as the fibrin-dominated matrix
grows under the activity of additional platelets recruited from the
bloodstream, focal areas of higher fibrin density may arise as old
erythrocytes lyse and the porous structure of the matrix becomes
sufficiently small to exclude the influx of new cells from the
lumen [11]. With continued loss of erythrocytes, increased sec-
ondary fibers form between the thick primary fibers, which could
contribute to a stiffening of the fibrin matrix (cf. Ref. [12]). Inter-
estingly, plasma samples from AAA patients form denser, lower
porosity clots that resist fibrinolysis more than controls, with the
degree of resistance correlating with aneurysm size [13]. These
findings appear to be independent of fibrinogen or changes in
thrombin generation; yet, other agents such as lipoprotein (a) or
activated factor XII (fXIIa) may affect clot structure independent
of thrombin [13]. Notably, lipoprotein (a) is elevated in AAA
plasma versus control [14], and fXII activity correlates with aneu-
rysm size [15]. These correlates may also contribute to the
increased stiffness observed during the aging of ILT [12].
The process of coagulation, the mechanical properties of fibrin,
and fibrinolysis are described in detail in several reviews [16–19]
and recent papers [11,20,21]. A number of computational models
have also been proposed for thrombus development, many of
which are reviewed in Xu et al. [22]. In general, two approaches
have been used to model coagulation and the development of
thrombus within flowing blood. Continuum models at the macro-
level include reaction-diffusion (differential) equations that
attempt to describe changes in the concentration and activation of
essential hemostatic factors. Illustrative examples of this approach
include Lobanov and Starozhilova [23], who were among the first
to model effects of flow on fibrin deposition to a thrombus
attached to a vessel wall and the subsequent effect of the growing
clot on the flow, as well as Anand et al. [24], who focused on both
the biochemical and mechanical factors governing thrombus for-
mation and lysis. Another, increasingly popular, approach
includes hybrid formulations that combine discrete and continuum
models. For example, since thrombin is generated on a nanoscale
while blood flows at a macroscale, a hybrid formulation attempts
to integrate these processes spatiotemporally and to take advant-
age of individual strengths of the different models. Illustrative
examples include Xu et al. [25,26], who combined a discrete cel-
lular Potts model for platelets, red blood cells, and white blood
cells with the continuum Navier–Stokes equations, and Biasetti
et al. [27], who investigated the relationship of flow vortices,
coagulation, and thrombus deposition while including both plasma
and membrane phase biochemical reactions. See, too, the works
by Leiderman and Fogelson [28], Scianna and Preziosi [29],
Flamm and Diamond [30], and others.
Many phenomenological models have also been employed to
identify potentially useful metrics for predicting the location and
timing of thrombus development within the aneurysmal sac. For
example, a particle-hemodynamics analysis by Basciano et al.
[31] suggested a generally greater maximum time-averaged shear
stress on simulated particles in the proximal and middle AAA as
well as a potential correlation between measures of near-wall par-
ticle transit times and future thrombus deposition. These findings
indirectly support computational results by Biasetti et al. [9,32],
which suggest that platelets can activate within proximal regions
of high fluid shear stress (e.g., flow vortices) and convect toward
the wall distally to deposit in zones of low wall shear stress.
Although larger sample sizes are needed to confirm and extend
these results, such studies are promising, indeed prerequisite, to
modeling the development of thrombus-laden AAAs over physio-
logically relevant timeframes. Timing and location of thrombus
deposition alone represent, however, only one aspect of under-
standing the role of ILT in AAA progression. Thus, we turn our
attention to the heterogeneous structure and inherent mechanical
properties of the thrombus itself.
3 ILT Structure and Mechanical Properties
Based on gross examination, two major types of ILT have been
described in AAAs: “discrete transition” and “continuous transi-
tion” [33]. In the discrete type, the thrombus appears to be lay-
ered, with sharp demarcations and weak attachments between
adjacent layers. Properties, therefore, are generally distinct among
the multiple (often three primary) layers. In contrast, in the contin-
uous transition thrombus, there are gradual transmural changes in
structure with strong radial connectivity. We suggest that these
differences could reflect the nature in which the thrombus was
formed; that is, by temporally separated discrete deposition events
resulting in various thicknesses versus a slow gradual build-up.
Interestingly, the aforementioned study by Basciano et al. [31]
appears to have captured a potential discrete deposition event (see
Fig. 1). Furthermore, noting that multiple studies have observed
both continuous and stepwise (or “staccato”) expansion of AAAs
[34,35], we hypothesize that the type of thrombus deposition (i.e.,
continuous versus discrete) may reflect, if not contribute to, these
modes of expansion. Future studies will be required to investigate
this possibility, however.
The three regions of layered ILT (Fig. 2) are often referred to as
luminal (nearest the blood), medial (or middle), and abluminal
(nearest the aneurysmal wall). The luminal layer appears red due to
the high content of erythrocytes, while the medial layer appears
white to yellow, due in part to the lysing of erythrocytes. In con-
trast, in thick ILT, the deepest (abluminal) layer may appear brown
[33,36]. In some cases (up to 40% of cases in one study [37]), a liq-
uid phase is also found at the interface between the abluminal layer
and the wall, suggestive of local liquefaction. It should be noted,
however, that not all ILT contain all three layers. Thin thrombi may
consist entirely of “luminal-type” thrombus, while thicker thrombi
may have a combination of distinct layers. There is, therefore, a
need to develop a more consistent and inclusive terminology to
describe the type of thrombus observed in future studies. Given
Fig. 1 Patient’s AAA volume history. Note the changes in vol-
ume of the lumen, ILT (thrombus), and aneurysmal sac over
time, with a possible discrete deposition of thrombus between
Jun. 2005 and Mar. 2006. From Basciano et al. [31], with kind
permission from Springer Science and Business Media.
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clear differences in biochemical and biomechanical properties of
the three layers, as determined by gross morphology, histology, and
mechanical tests, we suggest further that the terms “luminal,”
“medial,” and “abluminal” be used to refer to intrinsic differences
in clot type, not simply positions relative to the wall. That is, a
luminal thrombus should include all thrombi with certain specific
characteristics (e.g., high numbers of activated platelets and infil-
trating neutrophils) even if part of it is immediately adjacent to the
aortic wall. Thus, over time, a luminal thrombus may be buried by
subsequent clot deposition and evolve into medial and eventually
abluminal thrombi following erythrocyte lysis, leukocyte apoptosis,
and various degrees of fibrinolysis.
In terms of fibrin structure, the luminal layer is characterized by
thick primary fibers of fibrin with fine interconnecting secondary
fibers forming a well-organized matrix. These secondary intercon-
nections are lost in the medial layer with evidence of progressing
matrix degradation [33,36], consistent with the observation that
thin fibrin fibers cleave more quickly than thick ones [38]. This
finding is also consistent with the observation that small intercon-
nected channels termed “canaliculi” found throughout the ILT
appear to increase in mean area from the luminal toward the ablu-
minal layer [39]. Within the abluminal layer, the matrix is almost
completely degraded, with minimal fibrin organization [36].
Just as our understanding of structural characteristics of ILT has
increased significantly over the past few decades, so too has our
understanding of the mechanical properties. An early study by Di
Martino et al. [40] reported uniaxial, tensile data for circumferen-
tially oriented surgical samples of ILT and used a simple linearly
elastic Hookean model. While no distinction was made as to the
layer of ILT tested, only “well-organized” thrombi were selected for
testing, which likely reflects the luminal layer; reported Young’s
moduli were 0.05MPa to 0.2MPa. To quantify potential viscous
properties of ILT, both linear [33] and nonlinear [41] viscoelastic
models have been proposed. These results suggest that elastic
behavior dominates in multiple layers, though viscous effects may
be important in attenuating pressure waves. Although linearized
constitutive relations continue to be used, it has become increasingly
clear that such models cannot capture all responses [42,43]. This
finding should not be unexpected given that Vorp et al. [44] demon-
strated many years ago that ILT may undergo large strains in vivo.
Wang et al. [36] conducted uniaxial tensile tests on luminal and
medial layers of ILT in both circumferential and axial directions
and fit the data with a nonlinear, hyperelastic constitutive relation.
They reported distinct mechanical properties for two layers, with
increased stiffness and strength exhibited by the luminal layer;
results from circumferential and axial tests further suggested ma-
terial isotropy. Vande Geest et al. [45] similarly concluded that
the luminal layer was isotropic and nonlinearly hyperelastic using
biaxial tests; they were only able to test the luminal layer, how-
ever, noting that medial and abluminal layers were too weak.
Interestingly, they noted significant differences in the predicted
mechanical behavior when comparing results from the biaxial and
prior uniaxial results, highlighting the importance of appropriate
protocols when formulating constitutive relations. Indeed,
although tests are usually designed to explore tensile behavior,
Ashton et al. [46] used unconfined compression tests to calculate
a drained secant modulus at 5% strain for all three layers. Interest-
ingly, they reported significantly higher compressive stiffness for
abluminal than for medial and luminal layers, a gradient opposite
that observed in most tensile tests.
Recently, biaxial tests on all three layers by Tong et al. [12]
suggested the need to classify ILT even further by both position
Fig. 2 Gross and ultrastructural appearance of a layered intraluminal thrombus
from a human AAA. Note the entrapped cells in the luminal thrombus. From Wang
et al. [36], with permission.
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and age, due to possible evolving phases of development of the
mechanical and histological properties of each of the three layers.
Specifically, they observed a decreasing maximum tangential
modulus and tensile stress at failure from the luminal to the ablu-
minal layer but a potentially increasing tensile modulus for each
layer as it evolves through four phases over time (Fig. 3), most
notably in the axial direction for the luminal layer [12]. These
phases were histologically distinct (Fig. 4): Phase I (very fresh)
was characterized by an abundance of erythrocytes, Phase II
(young) by loose fibrin networks entrapping the erythrocytes,
Phase III (intermediate) by disrupted erythrocytes and a condens-
ing fibrin network, and Phase IV (old) by disrupted fibrin net-
works and condensed residue proteins. They also reported a
subclass of generally older luminal ILT that demonstrated aniso-
tropic behavior with increased stiffness in the axial direction.
Interestingly, associated mechanical testing of the underlying aor-
tic wall similarly revealed increased anisotropy when located
directly underneath an older, anisotropic ILT. Thus, biochemome-
chanical models of ILT may not only require delineation of the
layers of thrombus, but also their unique evolution in properties
and their influence on the mechanics of the underlying wall. This
consideration leads us naturally to the associated spatiotemporal
biochemical activity of ILT.
4 The Biologically Active ILT
Thrombus may occur throughout the body, including other
focal areas of ILT (e.g., deep vein or coronary thrombosis), yet
thrombi within AAAs are characterized by unique biochemical
and biomechanical properties secondary to their persistent contact
with flowing blood and their apparent inability to heal through
mesenchymal cell invasion and collagen deposition [47]. As a
result, ILT within AAA may contribute to the often chronic
inflammation of the underlying aortic wall, with persistent
renewal of cellular activity at the luminal interface via the aggre-
gation, entrapment, and recruitment of activated platelets and
inflammatory cells. Consequently, ILT can serve as a reservoir for
myriad proteases that can be released and activated during fibrino-
lysis. Any attempt to understand and model the effects of ILT on
AAA progression thus requires insight into not only its mechani-
cal properties and its often eccentric spatiotemporal distribution
within an aneurysm [48], but also its heterogeneous synthesis,
storage, and release of relevant biomolecules: mitogenic, syn-
thetic, proteolytic, and so forth.
4.1 Prominent Role of the Luminal Layer in ILT Activity
and Renewal. The luminal layer is the primary site in the ILT for
new thrombus deposition via activated platelets and cellular activ-
ity. Interestingly, cellular content almost exclusively remains iso-
lated to the luminal layer, with cells (including neutrophils,
macrophages, and lymphocytes) generally found only to a depth
of 1 cm, despite the aforementioned network of interconnected
canaliculi that permeate the ILT [39]. Circulating leukocytes, con-
sisting predominately of neutrophils, are actively recruited by and
Fig. 3 Maximum tangential moduli of ILT from human AAAs
separated by luminal (L), medial (M), and adventitial (A) layers
and phase (a proposed indicator of age; see Fig. 4). From Tong
et al. [12], with permission.
Fig. 4 Proposed histological phases of ILT maturation. From Tong et al. [12], with permission.
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retained in the luminal layer, aided by the exposure of P-selectin
by activated platelets and the affinity of neutrophils for binding to
the copolymer of fibrin-fibronectin in the clot [37]. Neutrophils in
the luminal layer can produce interleukin-8 (IL-8) and leukotriene
B4, which reinforce further neutrophil invasion [49,50]. Indeed,
in vitro tests confirm a potent neutrophil chemotactic activity of
the luminal layer that can be inhibited by antibodies to RANTES
or IL-8 or by the IL-8 receptor antagonist, reparixin [49]. Ulti-
mately, the neutrophil content of the luminal layer can be 12-fold
greater than that of blood [51].
Neutrophils are highly active cells that express and release a
number of proteolytic enzymes, including myeloperoxidase
(MPO), leukocyte elastase (LE), matrix metalloproteinases
(MMPs) 8 and 9, and urokinase-type plasminogen activator (uPA)
[52]. Lucent halos have even been observed around neutrophils in
regions of fibrin degradation [53], likely due to local activation of
plasmin via uPA or direct activity of secreted LE or cathepsin G
[54]. Notably, MMP-8 is a potent collagenase for type I collagen
whereas MMP-9 has specificity for partially degraded collagen
[52]. Both of these MMPs, along with MMP-2, are elevated in
AAAs, while the MMP inhibitors TIMP-1 and -2 are decreased
[52,55]. Nevertheless, both TIMP-1, released from platelet a-
granules [55], and the elastase inhibitor a1-antitypsin (a1-AT)
exist in the luminal layer, potentially explaining (along with la-
tency of the proform of the enzymes) some reports of high MMP-
9 and elastase levels in the luminal layer but low activity [56].
Indeed, a negative gradient of latent MMP-9 but positive gradient
of active MMP-9 has been reported from luminal to abluminal
layers of ILT [37]. Importantly, binding of an inhibitor to its target
can depend strongly on whether the protease is cell/matrix bound
or freely soluble; thus, there is a need for careful control and doc-
umentation of methods of measurement. Indeed, LE, MMP-9,
plasmin, and tissue plasminogen activator (tPA) can bind to fibrin
[47], whereas clot retraction and fibrinolysis can release proMMP-
9, elastase/a1-AT, MMP/NGAL (neutrophil gelatinase-associated
lipocalin), and RANTES [37,49].
Most proMMPs can be activated by other proteases (e.g., the
serine protease plasmin) or by reactive oxygen species and nitric
oxide [55]. An exception is the activation of proMMP-2, which
generally utilizes a membrane-type MMP on the cell surface, such
as MT1-MMP. While MMP-9 is frequently produced by inflam-
matory cells, the main source of MMP-2 in the aortic wall appears
to be smooth muscle cells (SMCs). This difference may explain
the predominant role of MMP-2 in small AAAs, when SMCs are
likely more abundant, compared to larger AAAs where MMP-9
activity is increased and SMCs are decreased [55,57]. Of note,
MMP-2 has a greater ability to degrade elastin than does MMP-9
[55], though MMP-2, -7, -9, and -12 all have activity against in-
soluble elastin [58]. Future studies are needed to quantify spatio-
temporal fluctuations of MMP levels and their respective
regulation by gene expression, zymogen activation, inhibition,
and inactivation [59]. In theory, temporal imbalances between
proteases and inhibitors could lead to a destabilizing increase in
matrix degradation (i.e., a “spike” in protease activity) that could
overwhelm the currently available inhibitors. For example, deliv-
ery of fresh blood deep within an ILT due to hemorrhage into the
thrombus (radiographically known as the “crescent sign”; see
Fig. 5) could release and activate numerous bound proteases from
the fibrin matrix that could overwhelm inhibitors and lead to rapid
degradation of the wall. Notably, in one study, the crescent sign
was seen in 21% (11/52) of ruptured aneurysms but 0% (0/56) of
asymptomatic nonruptured aneurysms [60].
While most thrombi tend to resolve over time, those in AAAs
show few signs of healing by endothelial cell coverage or mesen-
chymal cell invasion and replacement of the fibrin network with
collagen (cf. Ref. [61]). In vitro experiments reveal the inability
of SMCs to seed the luminal layer, likely due to the high proteo-
lytic activity. Indeed, luminal extracts induce anoikis of SMCs
and stromal cells of bone marrow origin, although this effect can
be blocked by protease inhibitors, including a1-AT. Notably, LE
can degrade fibronectin, a key adhesive protein for adherent cell
survival, and LE has been identified in neutrophils and the matrix
around dying cells in the luminal layer [47]. Neutrophils are also
capable of detaching endothelial cells from their underlying
extracellular matrix [47]. Ultimately, many neutrophils undergo
apoptosis (common in the luminal layer), which may lead to fur-
ther expression of chemotactic and procoagulant factors. Addi-
tionally, the luminal layer is characterized by high levels of
hemagglutination as erythrocytes deteriorate and release free he-
moglobin, a powerful oxidizing agent capable of forming free rad-
icals [51].
Of the cell-derived proteases produced within the luminal layer,
LE and MMP-9 are two of the most frequently studied enzymes in
AAA development. Notably, a significant correlation has been
observed between LE and MMP-9 when compared within the lumi-
nal, as well as abluminal, layer [56]. While MMP-9 can be inhibited
by TIMP-1, neutrophils can upregulate MMP-9 activity by releas-
ing NGAL, which binds MMP-9 and prevents its inactivation [48].
Interestingly, NGAL has been identified in ILT, interphase fluid,
and even aortic media not covered by thrombus, consistent with the
ability of NGAL to diffuse from thrombus to wall and/or to be pro-
duced by leukocytes invading from the vasa vasorum, including
monocyte derived macrophages [55]. LE can also increase MMP-9
activity by directly activating proMMP-9, indirectly activating it
through the activation of proMMP-3 [54], or by degrading TIMP-1,
thereby protecting MMP-9 from inhibition [52]. Of note, TIMP-1
not only can inhibit active MMP-9, it can also inhibit the activation
of proMMPs and neoangiogenesis [55].
In addition to cell-derived proteolytic activity, the luminal layer
is characterized by high levels of fibrinolytic activity, as evi-
denced by elevated release of plasmin-antiplasmin complexes
(PAPs) and D-dimers (a measure of cross-linked fibrin degrada-
tion), greater immunostaining for plasminogen and plasminogen
activators, and greater 99mTc-Aprotinin activity (a potential imag-
ing agent that binds serine proteases like plasmin and elastase)
compared with other layers [62]. Although fibrin may deposit
throughout the thrombus, it decreases significantly toward the
abluminal layer, consistent with activated platelets being predomi-
nately confined to the luminal layer [39]. Indeed, Touat et al. [53]
demonstrated that procoagulant activity and markers of platelet
activation were three to five fold higher in the luminal compared
with deeper layers. Yet, because activated platelets degranulate
within the clot [39], there is a potential for diffusion/convection of
biomolecules through the canaliculi. Overall, these findings sug-
gest possible continual cycles of fibrin deposition and degradation
within the luminal layer, indicative of an active remodeling and
renewal of the fibrin matrix [13,54]. Whether fibrin deposition
within the luminal layer could eventually become dense enough to
exclude further cellular infiltration (thus rendering the layer more
inert) remains to be proven, although findings by Tong et al. [12]
for older luminal layers having few erythrocytes supports this
possibility.
Fig. 5 Note the “crescent sign” on a contrast-enhanced CT
study of a 59 year-old male with an AAA. (Left—axial image;
Right—maximum-intensity projection reconstruction on an
oblique sagittal projection). From Labruto et al. [124], with
permission.
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4.2 Luminal ILT—Aortic Interactions. Because the ILT is
a heterogeneous structure, with its primary cellular activity in the
luminal layer, those elements of the aortic wall nearest the luminal
layer would be expected to be most at risk for proteolytic attack.
Indeed, aneurysmal walls covered by a thin (1.0 cm) thrombus
have significantly higher levels of LE activity, concentrations of
active MMP-9 and total MMP-8, and ratios of active MMP-9/
TIMP-1 than those covered by a thick (2.5 cm) thrombus [52].
MMP-9 and LE concentrations are also higher in luminal layers
compared with deeper layers, and a significant negative correla-
tion exists between the concentration and activity of LE in the
abluminal layer and ILT volume, suggesting that LE may not pen-
etrate well a thick ILT [56]. Of note, the slightly alkaline environ-
ment in the aneurysmal wall next to a thin ILT may also
accelerate local degradation by elastase [52].
In summary, the luminal layer of an ILT is a site of renewable
biochemical activity via the accumulation of platelets, recruitment
of proteolytically active leukocytes (notably neutrophils), formation
of fibrin, erythrocyte hemagglutination, and retention of tPA and
plasminogen for postponed progressive fibrinolysis [51]. With con-
tinued deposition of thrombus, either gradually or discretely, the
luminal layer may eventually become buried. This process could
trigger a unique evolution of properties of the ILT and underlying
aortic wall that must be considered in future modeling efforts.
4.3 Medial and Abluminal Layers. The medial layer is
characterized by a transition from the active cellular luminal layer
and the disorganized, degrading abluminal layer. It is generally
devoid of intact erythrocytes and only rarely has infiltrating leuko-
cytes despite a dense fibrin network. The abluminal layer is distin-
guished by its location adjacent to the aortic wall in thick ILTs, a
brown discoloration, lack of cells, degraded fibrin network, and
weak gelatinous material with high compressive stiffness [46,53].
Its interface with the aneurysmal wall may exist as a liquid inter-
phase with high levels of soluble proteins [37]. The lack of cellu-
lar content in the deeper layers of the ILT renders the clot unable
to synthesize new proteases in these regions; nevertheless, biomo-
lecules bound to the fibrin matrix during its formation in the
luminal layer may persist and be released and/or activated. As a
result, measurements of proteolytic activity in these layers may
potentially vary in time and space as well as from patient to
patient, depending on past and current fibrinolytic activity. For
example, Folkesson et al. [56] found abluminal proteases to be
predominately inactive whereas Fontaine et al. [37] reported
active MMP-9 at the liquid interface between the ILT and wall.
The ability of the degrading fibrin matrix to release bound
proMMPs in the presence of plasmin (potentially formed by a ready
supply of plasminogen activators, such as tPA, in the immediately
adjacent wall [62]) may activate MMPs at the interface and cause
subsequent degradation of the underlying wall. Indeed, the aneurys-
mal wall has shown 100-fold higher tPA activity than the ILT [63],
and MMP-9 activity has been localized to the inner wall of AAA
[64] as has elastase activity [52] and plasmin [65], consistent with
an ILT-mediated degradation of the wall. Yet, remnant SMCs, infil-
trating macrophages, and endothelial cells from the vasa vasorum
may also produce MMP-9 [66], which may relate to the ability of
these cells to migrate toward and neovascularize the injured aortic
wall. For example, noting that plasmin is a key activator of
proMMP-9, plasminogen-/- mice had reduced macrophage migra-
tion through the extracellular matrix that was rescued with adminis-
tration of active MMP-9 [67]. Nevertheless, increased MMP-9
activity in the wall significantly exceeded the increase in MMP-9
expression [66], consistent with diffusion/convection from the ILT
and/or increased release and activation of stored MMPs.
It remains to be shown whether deeper layers of ILT may even-
tually become depleted of stored pro-enzymes as they degrade. If
so, their level of proteolytic activity may vary depending on the
spatiotemporal availability of activators and inhibitors, leading to
a potentially significant source of patient variability in proteolytic
activity. Indeed, there is a large range of reported MMP-9 levels
in the ILT, interface, and wall (e.g., see Fig. 3 in Fontaine et al.
[37]), thus highlighting the need to develop improved patient-
specific methods of determining proteolytic content and activity
in thrombi. We suggest, therefore, that while averaged data on
biochemical potential and activity are insightful for population-
based studies, patient-specific determinations of rupture risk may
benefit from individualized spatiotemporal assessment of key
enzymes and regulators or at least localized measures of net pro-
teolytic activity.
4.4 The Fibrinolytic System and AAAs. Just as LE, MMPs,
and other proteases are important in AAA development and pro-
gression, the fibrinolytic system is fundamental to regulating the
ILT. Plasminogen, synthesized by the liver and released into the
blood, is naturally bound within the fibrin matrix during its forma-
tion and is present in large quantities in thrombus [54]. Cleavage
of plasminogen, classically by uPA or tPA, to the potent serine
protease plasmin results in many proteolytic consequences,
including direct degradation of fibrin and extracellular matrix
[54], direct or indirect activation of various proMMPs (including
MMP-1, -3, -7, -9, -10, -12, and -13) [55,62,67], regulation of
growth factors and chemokines [68,69], and proteolysis of cellular
anchoring fibers, which may induce anoikis [51,70]. Plasmin can
also exert a fibrin-catalyzed positive feedback to activate
additional plasminogen [68]. The major inhibitory proteins in the
fibrinolytic system are plasminogen activator inhibitor 1 (PAI-1),
which inhibits uPA and tPA, and a2-antiplasmin (a2-AP), which
binds to and inhibits active plasmin to form PAP complexes.
Interestingly, while plasmin can activate MMPs, MMPs can also
affect the fibrinolytic system. For example, activation of
proMMP-9 by MMP-3 can cleave plasminogen and inactivate
PAI-1, a2-AP, and a1-AT [54]. Similarly, elastase can indirectly
activate plasminogen through alternative pathways [56].
While some report that the luminal layer releases most of the
D-dimers [62], indicating degradation of fibrin, the medial and
especially abluminal layer appear to undergo greater net fibrinoly-
sis, likely due to the lack of significant new fibrin deposition
within these deeper layers. Suggestive of abluminal plasminogen
activation by activators in the inner wall, Fontaine et al. [37]
reported that free uPA and tPA activities were only noted in the
wall, while plasminogen was identified only in the ILT; however,
Houard et al. [62] later reported that while tPA in the wall local-
izes to the inner media (and vasa vasorum in the adventitia), abun-
dant tPA and uPA immunostaining are also present in the luminal
ILT, potentially bound to fibrin and associated with neutrophils,
respectively. Co-incubation of ILT and wall extracts in the pres-
ence of fibrin also produces plasmin in vitro [37]. The degree to
which patient-specific and layer-specific variability in the samples
of thrombi tested influence these results may require further
consideration.
Notably, PAI-1 and a2-AP may not be as effective in inhibiting
plasmin activity when their targets are bound to fibrin or the cell
surface [54,70]. Since plasminogen, tPA, and plasmin can each
bind to fibrin (as can a2-AP) [54,71] and localize to fibrin-rich
areas in the luminal layer [62], they could potentially exert local
activity before becoming soluble and thereby vulnerable to
increased inhibition. Thus, PAPs are often present in areas of
active fibrinolysis, such as the thrombus-wall interface [37], even
though they are inhibitory complexes. In fact, a positive correla-
tion exists between PAPs and D-dimers in all ILT layers [62]. In
addition to decreasing inactivation, binding of plasminogen, such
as to an inducible cell surface receptor, may also increase its acti-
vation and serve to direct its proteolytic activity to specific targets
[68]. Clearly, therefore, it is important to report and interpret
measures of fibrinolytic enzymes (and MMPs) carefully in terms
of their expression (mRNA), storage/binding (stained), or release
(solubilized) as well as whether the protein is latent, activated, or
inhibited. For example, upregulation of a particular gene may lead
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to increased transcription and translation of a protease or cytokine
but no immediate increase in its extracellular activity due to intra-
cellular storage or release of only the latent form.
Synthesis of tPA and PAI-1 appear isolated to the wall, while
uPA is expressed by inflammatory cells within the wall and lumi-
nal layer of the ILT [37,62]. Interestingly, SMCs can use constitu-
tive tPA on their cell surface to locally activate plasmin and cause
pericellular proteolysis of attachment molecules like fibronectin
[70], a process potentially involved in activation, migration, and/
or anoikis in the aortic media; tPA also localizes to the adventitia,
possibly related to its release by endothelial cells of the vasa vaso-
rum [62]. As for PAI-1, it has been highly stained in the luminal
layer of the ILT but most readily released from the medial and
abluminal layers consistent with its strong affinity for the cc-fibrin
chain, which is intact in the luminal layer but degraded in deeper
layers [62]. Given the significant ability of the fibrinolytic system
both to remodel the ILT and regulate proteolysis of the extracellu-
lar matrix of the underlying wall, the spatiotemporal distribution
of plasmin, its activators, and its inhibitors represent key data that
could improve future patient-specific models of AAA progression
and rupture risk.
4.5 A Unique Role for Matrikines? Despite appropriate em-
phasis on proteolytic enzymes that directly affect the remodeling
of fibrin and extracellular matrix, degradation products of matrily-
sis (including elastin [72], laminin [73], and fibrin [74]) are not
simply removed. Rather, these products may serve as active sig-
naling and catalytic molecules, termed matrikines [54], which
help regulate inflammation, repair, angiogenesis, and other proc-
esses. Of these, the elastin degradation products (EDPs) are likely
of particular significance in AAAs given their chemotaxis for
monocytes, neutrophils, fibroblasts, and endothelial cells [75],
stimulation of the release of elastase in the wall by neutrophils
[52], augmentation of MMP-1 production by aortic SMCs, promo-
tion of angiogenesis [75], and influence on the differentiation of
Th1 cells that can upregulate interferon-c (IFN-c) and interleukin-
2 (IL-2) [48].
Interestingly, Nackman et al. [75] demonstrated that perfusion
of a segment of the infrarenal aorta in a rat with an elastin peptide
fragment (VGVAPG) could reproduce the extensive neovasculari-
zation of the wall that occurs in a classic rodent model of AAAs
(by direct perfusion of the aorta with elastase), despite the aortic
diameter increasing only 26% following perfusion with the pep-
tide fragment instead of 142% with elastase. This importance of
elastin breakdown products stimulating neovascularization (as
opposed to just hypoxia from a thickening ILT) may explain, in
part, why significant differences in neovascularization were noted
between aneurysmal walls and control aorta but not between thick
versus thin thrombus covered aneurysmal walls [65] or thrombus
covered versus noncovered aneurysmal walls [76]. Faisal et al.
[73] similarly showed that a laminin peptide found in AAAs, due
to release from the degrading ECM, can upregulate uPA and
MMP-9 in macrophages. Notably, laminin is a susceptible target
of plasmin degradation [77]. Finally, fibrinogen derived peptides
may increase leukocyte chemotaxis and permeability of the aneur-
ysmal wall [78].
In healthy aorta, the media has been considered an immunologi-
cally “privileged” site to which immune cells have minimal access
[79,80]; yet, when the well-organized elastic lamellar units are dis-
rupted, otherwise inaccessible antigens and degradation products
may become exposed and participate in the observed shift from
innate to adaptive immunity in AAAs. In addition to EDPs, these
local mediators may include post-translationally modified proteins,
reactive oxygen species (ROS), and bi-products of SMC apoptosis
[78]. Proteolysis of extracellular matrix can also release and acti-
vate transforming growth factor b (TGF-b), a key biomolecule in
the regulation of collagen synthesis and secretion [78]. Notably,
plasmin at cell surfaces is an activator of TGF-b [81], and whether
via TGF-b or other factors, increase in pro-collagen gene expres-
sion in AAAs is mediated by soluble tissue factors [82]. Indeed,
even in regions beyond the infrarenal aorta, AAAs have been
associated with increased aortic collagen, elevated expression of
MMP-2 by SMCs, diffuse arteriomegaly, arterial elongation, and
peripheral aneurysms, which suggest a widespread process [82–85].
Whether this process is causal or responsive to the aneurysm is yet
unknown.
4.6 Convection/Diffusion. Adding to the complexity of iden-
tifying the major proteolytic enzymes and signaling molecules
that influence AAA progression, these macromolecules likely con-
vect/diffuse through the canaliculi of the ILT toward the underly-
ing wall. Adolph et al. [39] showed, for example, that ILT is fluid
permeable, although diffusion becomes limited across very thick
thrombi. Levels of LE and MMP-9, which are produced predomi-
nately in the active luminal layer, decrease through the depth of
the ILT [56]. Similarly, proteases, degradation products, antigens,
and other soluble biomolecules may be transported radially
through the aneurysmal wall toward the adventitia, which can
play a major role in arterial responses to disease, including fibro-
blast activation, neovascularization, immunoinflammation, and fi-
brosis [78]. It is also likely that the permeability increases as the
endothelial lining is lost [76] and the organized structure of the
healthy aortic wall is degraded [51]. Along these lines, recent
attempts at modeling the thrombus and aneurysmal wall as poro-
hyperelastic structures [86,87] may provide insight into the com-
plex interstitial fluid flows in thrombus-laden AAAs. Thus, a
complete model of the biochemical influences of various media-
tors may require accurate quantification of the transmural hydrau-
lic conductance, diffusion down concentration gradients, binding
affinities, and wall permeability [78].
4.7 Role of Animal Models. In concluding our discussion of
biochemical processes in ILT, note that diverse animal models
have been used to study AAAs because of the difficulty of obtain-
ing human tissue, particularly under controlled longitudinal condi-
tions. The two most common animal models of AAAs that can
also lead to formation of thrombus are the angiotensin II (Ang-II)
infusion model [88] and the elastase intraluminal perfusion model
[89]. The former involves subcutaneous implantation of an os-
motic mini-pump whereas the latter involves direct perfusion of
the infrarenal aorta during open surgery. Note that the Ang-II
model is typically used in Apo-E deficient mice and produces dis-
secting aneurysms in the suprarenal aorta, as opposed to dilatory
aneurysms in the infrarenal aorta as classically seen in humans.
Moreover, intramural thrombi within the dissected wall in the
Ang-II model can heal through cellular invasion and eventual
replacement of the fibrin matrix with collagen [61]. Thus, the nat-
ural history of AAAs in the Ang-II infusion model may have dis-
tinct differences from the human pathology, particularly in terms
of thrombus formation and evolution.
In contrast, although the elastase perfusion model tends not to
yield ILT in mice, the same experiment in rats often does, and the
aneurysms are appropriately in the infrarenal aorta. Using this
model, Coutard et al. [71] demonstrated higher levels of MMP-9,
elastase, uPA, plasmin, and microparticles in the ILT compared
with the wall, while MMP-2 activation was similar. Interestingly,
ILT correlated positively with wall levels of pro- and active
MMP-2, elastase, and plasmin, whereas total wall MMP-9, MMP-
2 activation, plasmin activity, and microparticle release correlated
with aneurysm diameter. The potential importance of these and
other factors in future modeling and therapeutic efforts is high-
lighted by the attenuation of aneurysmal development in various
experimental models of AAA by depletion of neutrophils, T-cells,
macrophages, or mast cells [76,90], inhibition of platelet activa-
tion [91], inhibition of neutrophil recruitment [92,93], knockout
of plasminogen [67], deficiency of uPA [94], knockout of MMP-
2, -9, or -12 [95,96], or increases in PAI-1 [97], TIMP-1 [98], or
catalase [99].
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5 Role of ILT in AAA Wall Mechanics
5.1 Clinical and Experimental Observations. While our
primary focus thus far has been on biomechanical properties of
and biochemical processes within the ILT itself, numerous studies
have attempted to determine effects of the ILT on the underlying
wall. Compared to a thrombus-free wall, the wall beneath an ILT
may have increased inflammation and neovascularization as well
as fewer elastic fibers and smooth muscle cells, many of which
are apoptotic [100]. An increase in phenotypically synthetic
SMCs, many with elongated processes suggesting ongoing migra-
tion, has also been noted [76,100]. In comparison, an aneurysmal
wall without ILT can have a dense collagenous matrix with phe-
notypically contractile SMCs and increased staining for a-actin
[100], although expression of MMP-1, -7, -9, and -12 can be higher
than in the covered wall [101]. While both thrombus-covered and
thrombus-free wall exhibit increased CD68þ macrophage counts
and caspase-3 staining for apoptosis, the thrombus-covered wall can
also have increased CD3þ T-cells, CD8þ cytotoxic T-cells, and
CD20þ B-cells, along with increased TUNEL staining for DNA
fragmentation in the intima and media, often in association with
inflammatory cells [100]. Clearly, there are significant differences
in the structure of the matrix, cellular content, and inflammatory sta-
tus of the wall underneath an ILT that require further investigation
to improve future modeling.
Interestingly, the thrombus has been found to be thinner, on av-
erage, in ruptured versus nonruptured aneurysms [52], though
thick thrombus covered walls may have fewer remaining elastic
fibers, more inflammation, and lower tensile strength compared
with walls covered with thin ILT [65]. A possible reason for this
apparent discrepancy is that any wall covered by thick thrombus
likely was originally covered by thin thrombus (i.e., a luminal
layer in direct contact with the wall); thus, changes may reflect cu-
mulative damage from the past because intact lamellae are not
regenerated in adulthood. One may hypothesize, therefore, that
the most active degeneration of the wall occurs in regions of thin
thrombus and that thickening of the ILT with subsequent deposi-
tion events may be somewhat protective, at least insofar as the
wall is farther from the active luminal layer. In fact, if a thin
thrombus presents excess proteases to the wall, which in turn
heightens wall degeneration and lesion expansion, and if expan-
sion leads to hemodynamic changes conducive to new clot deposi-
tion, then one would naturally expect thrombus to thicken in
regions of significant wall degeneration (provided that a rupture
does not occur first). Indeed, loss of elastin may primarily cause a
decrease in axial support, leading to an elongation and tortuosity
of the aorta that may induce endothelial injury due to disturbed
blood flow and abnormal wall stress [48]. Thus, despite an
increased aneurysmal diameter correlating with both increased
rupture risk and ILT volume in some reports [48,55], one must
interpret cautiously possible causation as the expanding geometry
and associated hemodynamic changes may naturally precipitate
further ILT deposition. Nevertheless, the growth rate of ILT in
moderately sized AAAs may be a better predictor of rupture risk
than total amount of ILT or the common metric of maximum di-
ameter of the lesion [102], which potentially explains why a sim-
ple static ratio of lesion size to ILT volume has been unrevealing
when comparing ruptured and nonruptured AAAs [48,103].
Alternatively, or perhaps complementarily, the fibrinolysis that
predominates in the abluminal layer may release and activate pre-
viously bound or soluble proteases (e.g., plasmin or MMPs) that
could then diffuse into the adjacent wall and directly degrade the
ECM or activate other proteases, thus contributing to the
increased degradation behind thicker thrombi. Additionally, thick
thrombi may also exacerbate hypoxic conditions in the wall that
may contribute to neovascularization from the vasa vasorum or
even alter collagen production [65,104], though a convection/dif-
fusion model of oxygen transport by Sun et al. [105] suggested
that thickening of the ILT beyond approximately 5mm may not
have much more effect on mural oxygen tension. Of note, forma-
tion of these neovessels not only requires proteases for endothelial
cell invasion, it establishes a direct path for circulating inflamma-
tory cells to invade the degenerating media. Indeed, inflammatory
cell retention, elastin degradation, and lymphoid neogenesis all
correlate with adventitial neovascularization [78].
5.2 Implications of Spatial Distribution—The Shoulder
and Neck Regions. Multiple studies have focused on the
shoulder regions of the AAA (i.e., proximal and distal regions
between the dilated and nondilated aorta) as they may both reflect
“early” stages of aneurysmal development (which are difficult to
study due to the asymptomatic nature of the early disease process)
and represent regions that may dictate the axial expansion of the
lesion into the proximal and distal necks (i.e., the adjacent nondi-
lated areas) of the infrarenal aorta. Moreover, the proximal neck
is particularly important clinically as the location for seating the
endovascular stents that are increasingly used for AAA repair.
Assuming the thrombus approximately “space-fills” the dilated
portions of the body of an AAA (see Fig. 6), the active luminal
layer of the ILT would always remain in contact with the evolving
shoulder of an aneurysm. As suggested by Yoshimura et al. [106],
this situation would predict increased thrombus-derived proteases
in the shoulders of the lesion. Indeed, Curci et al. [58] observed
that areas of “active” elastic lamellar degradation predominated in
the proximal shoulder region, while the body of the lesion con-
sisted of mostly “amorphous” fibrocollagenous regions with few
remaining elastic fibers and only scattered “inflammatory” and
active regions. The shoulder also appears to be a site of increased
MMP-9 activity, decreased medial thickness, fewer intact lamellar
units, and increased phosphorylated c-Jun N-terminal kinase
(JNK), inflammation, and neovascularization [66]. Notably, JNK
may be a pivotal intracellular signaling molecule in SMCs and
macrophages that can be upregulated by a plethora of biomole-
cules frequently associated with AAAs, including MMP-2 and 9,
Ang-II, histamine, interleukins, IFN-c, and tumor necrosis factor
a (TNF-a) [66,76]. Interestingly, expression of both TNF-a and its
activating enzyme TACE are not only higher in AAAs compared
to control aortas, they are also higher in the neck compared with
the apex of the lesion, where they colocalize with macrophages of
the media and adventitia. TNF-a can also induce other inflamma-
tory cytokines and several MMPs, promote apoptosis, and
increase uPA, tPA, and PAI-1 levels (which are pro-angiogenic)
[107]. The delivery of a TNF-a specific binding protein has even
been shown to prevent AAA formation in a rat elastase perfusion
model [107].
Early damage to the aortic wall is not confined to the shoulder,
however. Increased degeneration in the nonaneurysmal neck
region has been associated with maximum AAA diameter [66],
and the neck can be a site of early inflammatory cell infiltration
with elevated levels of MMP-12 strongly bound to elastic fiber
fragments, which may augment its elastolytic activity [58]. In
comparing samples of aneurysmal necks from different patients,
those with mild degeneration were characterized by damage to
inner medial elastin with some mid-medial and patchy outer-
medial loss of SMCs, while more heavily damaged samples
showed widespread degeneration with significant loss of smooth
muscle in the outer media [66]. This observation may suggest an
initial process of damage to the inner wall, particularly to the elas-
tic fibers, followed by a strong adventitial response.
Computationally, many finite element studies suggest that the
highest values of wall stress occur at sites other than the maximal
diameter. Li et al. [108] specifically suggested that elevated
shoulder stress associates with rapidly expanding AAAs. Our own
growth and remodeling simulations [109] also suggest that the
shoulder represents a region where elastin may fail mechanically
as an aneurysm enlarges, thus leading to steep gradients in stress.
Our computational models of AAAs expanding axially against
fixed ends (e.g., at the renal arteries and iliac bifurcations) also
predict decreasing axial stress in the neck and shoulder regions,
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which suggests a potentially increased risk of tortuosity (e.g.,
buckling) [110]. Consistent with the idea that elongation and tor-
tuosity may result from elastin degradation [48], our computa-
tional results may potentially link changes in the neck and
shoulder regions with the induction of disturbed flow and subse-
quent thrombus deposition. Interestingly, hemodynamic simula-
tions within our lab and others also demonstrate regions of
backflow in the proximal neck of the aneurysm, which may con-
vect important biomolecules, including proteases and inflamma-
tory mediators, from nearby thrombus to the proximal neck.
Indeed, NGAL-MMP-9 complexes, which are abundant in the
luminal layer, have been found in the neck [66], though they
might also originate from early infiltrating leukocytes in the wall
as well. In addition, thrombin and fibrin from the nearby thrombus
may activate endothelial cells, which are still present in the neck
and possibly shoulder regions, to increase production of tPA and
uPA [24] and thus potentially affect ILT remodeling.
We suggest, therefore, that particular attention be given to the
neck and shoulder regions of the AAA, including their biome-
chanical and biochemical properties, their role in the axial expan-
sion of the aneurysm, and their relation to nearby thrombus.
Future data regarding changes in these regions may provide im-
portant clues to understand early aneurysm formation and tortuos-
ity that may ultimately guide new therapeutics, such as stent
seating and design, and improve future G&R models, which must
account for the evolving nonaneurysmal aortic regions in the mod-
eling domain.
5.3 ILT Shielding, Attachment, and Compressibility. It
has long been appreciated that mathematical models of the
aneurysmal wall can provide important insight into the biome-
chanics, and thus structural stability, of these potentially life-
threatening lesions. While the earliest models did not include ILT,
their incorporation into models of AAAs has developed over the
past two decades from axisymmetric [111,112] to 2D eccentric
[40] and finally to fully 3D patient-specific geometries [113–116].
The majority of these computational studies, as well as an in vitro
experimental study using a synthetic AAA model with thrombus
[117], support the initial work by Inzoli et al. [111] that an ILT
may provide a mechanically protective effect (i.e., a “cushioning”
or “shielding”) by reducing the stress on the aneurysmal wall; yet,
others question the ability of the porous thrombus to reduce wall
stress consistently, as assessed computationally [118] or by direct
intraoperative pressure measurements in vivo [119]. Clearly, con-
troversy remains.
Two important factors in determining the presence or extent of
this potential stress shielding are the attachment of the thrombus
to the underlying wall and the degrees of porosity and compressi-
bility of the ILT. Adhesion of platelets to collagen has been inves-
tigated extensively, but connection of fibrin to the aneurysmal
wall has not. As noted earlier, several papers report a “liquid
phase” at the interface between the ILT and wall [37,48], suggest-
ing that the thrombus may not be attached to the wall, at least in
some instances. The type of thrombus layer in contact with the
wall may also affect the degree of attachment; that is, an actively
remodeling thin luminal layer in direct contact with an aneurys-
mal wall could be attached differently than a degenerated ablumi-
nal layer as observed in many thick ILT. Most finite element
analyses that include ILT have assumed its perfect attachment to
the wall. While a potential reduction of intraluminal pressuriza-
tion of the wall by the ILT could reduce wall stress, Meyer et al.
[118] showed that the thrombus can still have a stress-reducing
role even if it does not directly reduce pressurization on the wall
as long as the ILT is fully attached. With only partial attachment,
however, a porous thrombus capable of transmitting pressure also
has the potential to generate stress concentrations and increase
wall stress. Clearly, there is a pressing need for greater experi-
mental insight to resolve this question since any estimation of
stress distributions, and thus rupture risk, will depend on the me-
chanical tethering of the ILT and wall.
Fig. 6 Top: Simplified schema of the possible formation of a layered “space
filling” ILT by multiple cycles of AAA sac enlargement and ILT deposition second-
ary to disturbed flow. Note that the specific initiation site in 3 is merely schematic.
Bottom: Cross-sectional view at two different axial locations at one instant, when
the luminal ILT layer (black) may remain in contact with the wall at the shoulder
region while being distant from the anterior wall at the apex of the lesion. (Diagram
by Carolyn Valentı´n).
Journal of Biomechanical Engineering FEBRUARY 2013, Vol. 135 / 021011-9
The compressibility of the ILT will also directly affect its me-
chanical behavior and its ability to shield the aneurysmal wall.
Using noninvasive ultrasound, Vorp et al. [44] suggested that ILT
is incompressible, and the vast majority of computational works
to date have invoked incompressibility when modeling ILT. Yet,
some question this assumption. In vitro experiments on fibrin gels
demonstrated a dramatic decrease in clot volume due to water
expulsion (and thus manifold increase in protein content) with
negative compressibility upon stretching [120]. This volume
change may be associated with the exposure of hydrophobic
groups upon protein unfolding and bundling of stretched fibrin
fibers. Of note, the compressibility of the fibrin gels was limited
to strains of 0.5, as further stretching did not alter volume. Pro-
vocatively, an in vivo study by Truijers et al. [121] that quantified
volumes of lumen, intraluminal thrombus, and whole AAA
through the cardiac cycle in 17 patients using dynamic
electrocardiographically-gated CT angiography showed wide
patient-specific variability (0.4% to 43.6% compressibility by vol-
ume between diastole and peak systole). No correlation was found
between compressibility of thrombus and aneurysm size, throm-
bus volume, or pulse pressure. Since this study analyzed the vol-
ume of thrombus within the entire aneurysm, no distinction can be
made between the compressibility of the heterogeneous layers of
ILT that may possess different inherent mechanical properties and
times of deposition; nevertheless, this study strongly suggests that
not all ILT are incompressible. Furthermore, since thrombus is
constantly evolving, the compressibility of a given ILT may
change over time. The potentially evolving compressibility of ILT
may not only affect its stress-shielding of the wall (and require a
reformulation of the constitutive relations used for its mechanical
modeling), it may also significantly affect the transport of key bio-
molecules produced by the ILT. Clearly, studies are needed to
determine the compressibility, attachment, and stress buffering
capability of ILT in a patient-specific manner, as some ILT may
provide significant shielding effects while others may not.
5.4 Strength and Failure of the ILT and Wall. Aneurysms
rupture when local wall stress exceeds wall strength [3]. Hence,
including the potential ability of ILT to alter spatiotemporally
both the mechanical stress and the inherent strength of the under-
lying aneurysmal wall may improve our ability to predict patient-
specific rupture risk. Indeed, Vande Geest et al. [122] already
proposed ILT thickness as a key parameter in formulating a statis-
tical estimate of wall strength, and Tong et al. [12] showed that
aneurysmal wall underneath older thrombus was generally weaker
in the high loading domain during biaxial testing compared with
that under young thrombus.
Gasser et al. [123] tested the hypothesis that mechanical failure
of ILT itself could lead to subsequent AAA rupture. They sub-
jected specimens of luminal, medial, and abluminal ILT to uniax-
ial fatigue and strength tests and concluded that ILT fails before
the wall. Indeed, CT evidence suggests that focal hemorrhage into
the ILT, described radiographically as a “crescent sign” (Fig. 5,
Ref. [124]), associates with an increased risk of rupture or
impending rupture [54]. Such a failure could not only expose the
wall to increased stress (if the assumption of stress-shielding by
the ILT is true), the fresh hemorrhage into the ILT could also
weaken the underlying wall structurally via the delivery and
release of active proteases (as discussed earlier), both of which
may increase rupture risk.
In addition to revealing the crescent sign, medical imaging may
provide further insights into the mechanics and interactions of the
ILT and aortic wall that could significantly advance the assessment
of rupture risk by revealing patient-specific properties of the throm-
bus and wall noninvasively. For example, Nchimi et al. [125]
reported a correlation of phagocytic leukocytes and changes in
magnetic resonance signal via the use of superparamagnetic iron
oxide (SPIO) at the luminal interface of the thrombus, thus suggest-
ing a potential means of determining activity of the luminal layer.
Later, Richards et al. [126] showed that distinct mural uptake of
ultrasmall SPIO (or USPIO) in the aneurysmal wall associated with
a three-fold higher expansion rate than no or nonspecific USPIO
uptake despite similar maximum diameters. This finding is consist-
ent with the idea that active areas of inflammation augment the deg-
radation and remodeling of the extracellular matrix and hence
influence expansion. Moreover, MRI may help differentiate distinct
layers of ILT within some aneurysms in vivo (e.g., see Fig. 7
[124]). Whether these layers correspond to the biochemically and/
or biomechanically distinct layers discussed herein requires future
investigation. Nevertheless, the potential for medical imaging to
inform the next generation of patient-specific G&R models of
AAAs holds significant promise.
6 Modeling Aneurysmal Growth and Remodeling
As the word itself implies, biomechanics requires an under-
standing and description of both the biological and the mechanical
aspects of a system. In this review, we have attempted to highlight
both of these aspects in regards to intraluminal thrombus in ab-
dominal aortic aneurysms. What remains, however, is a merging
of the two into a computational framework capable of quantifying
and predicting how the biology and mechanics interrelate. For
example, hyperelasticity may be used to describe a thrombus at a
given instant, but such a description could just as easily be
assigned to a nonliving polymer gel. What distinguishes the meta-
bolically active thrombus from the inanimate gel is the ability of
the incorporated platelets and cells to actively change the mass
and interconnectedness of the fibrin matrix over time, that is, to
grow and remodel. A G&R approach to modeling biological sys-
tems thus has the potential to describe evolving mechanical prop-
erties (e.g., mass, stiffness, failure criteria) over physiologically
relevant timeframes as a function of local biological, chemical,
and mechanical factors such as cellular content, protease levels,
and hemodynamic loads. Ultimately, this is the challenge facing
the clinician—not only determining immediate risk of rupture but
Fig. 7 Comparison of a contrast-enhanced CT image (left) and a T2-weighted MR image (right)
of an AAA in a 49 year-old male. Note the clear layers of the ILT evident in the MRI that are not
delineated by CT. From Labruto et al. [124], with permission.
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also risk over the subsequent months to years so that the timing of
follow-up with reimaging or surgical intervention may be selected
appropriately for a given patient.
The first G&R model to describe AAA evolution was presented
by Watton et al. [127] in 2004. They modeled the wall as a two
layered cylindrical membrane described by a constrained mixture
[128], with structural properties determined by the nonlinearly
elastic collagen and elastin. They considered the development of
both axisymmetric and asymmetric aneurysms caused by pre-
scribed focal degradations of elastin, with potential limitation of
posterior expansion due to the spine. This G&R framework was
later extended to include fluid-solid-growth (FSG) modeling by
Watton et al. [129] in 2009.
Other recent models [109,110,130,131] also employed the con-
cept of evolving constrained mixtures to investigate AAA
mechanics but with different constitutive functions and implemen-
tations. For example, instead of using a “recruitment stretch” to
characterize when collagen becomes engaged mechanically, they
used the concept of a “deposition stretch” to model incorporation
of prestressed fibers within the in vivo geometry. Since new fibers
are always added at a prescribed homeostatic deposition stretch
while old fibers are removed, the wall as a whole can reestablish a
homeostatic state provided that the forces favoring expansion
(e.g., intravascular pressure and degradation of extracellular
matrix) do not exceed the capacity of the wall to produce new ma-
terial. Wilson et al. [110] further suggested that the range of
potential clinical endpoints (arrest, continued expansion, or rup-
ture) depended strongly on G&R parameters governing collagen
turnover (e.g., production rates, degradation rates, deposition
stretch, and stiffness). A more detailed review of past finite ele-
ment studies of AAA wall stress and growth and remodeling can
be found in Humphrey and Holzapfel [2], and a review of the
need for fluid-solid-growth models of AAAs can be found in
Humphrey and Taylor [1].
Nevertheless, current models of aneurysmal G&R do not include
directly the biochemical effects of intraluminal thrombus. For
example, the aforementioned release of plasmin in a particular
region of the ILT may activate available proMMPs and lead to a
local change in the G&R parameter controlling the degradation rate
of collagen. At the same time, the now active MMPs could activate
latent TGF-b that had been sequestered in the extracellular matrix
and, thereby, increase the G&R parameter governing growth factor
mediated collagen production. We suggest, therefore, that there is a
pressing need to develop biochemomechanical constitutive models
to correlate the spatiotemporal activity of key proteases and media-
tors (e.g., plasmin, MMPs, elastase, TGF-b, TIMPs) produced and
activated by the ILT and wall with the governing G&R parameters
that control the turnover of the primary load-bearing constituents
within the wall, most notably, collagen, elastin, and smooth muscle.
Indeed, similar models of the turnover of load-bearing constituents
within the ILT will also be needed [132]. Given the inherent com-
plexities in the biology and mechanical modeling, advances will
likely need to proceed stepwise, building from lumped parameter
models towards eventual multiscale, multiphysics models. Towards
this end, we present an initial schema (Fig. 8) outlining the interac-
tions of key contributors likely affecting the growth and remodeling
of thrombus-laden AAAs. Indeed, the ability to identify and mea-
sure such lumped parameters noninvasively and patient-specifically
(e.g., leukocyte content of the ILT by USPIO uptake or collagenase
activity in the wall by MMP-targeted MRI agents) is increasingly
becoming available to provide the necessary data to inform the next
generation of biochemomechanical G&R models of AAAs.
7 Conclusions
We have attempted to draw attention to complementary biolog-
ical, chemical, and mechanical characteristics of ILT and their
potential roles in the natural history of AAAs. Given this back-
ground, we suggest that appropriate biochemomechanical models
of the G&R of thrombus-laden AAAs can be constructed using
existing theoretical frameworks, including the constrained mixture
theory [128]. These models require three classes of constituent-
specific constitutive relations: stored energy functions that
describe the mechanical behaviors plus production and removal
functions that describe chemomechanical mediated turnover of
structural constituents. To encourage experimentation that will
provide the requisite data for developing and validating such mod-
els, we suggest four aspects of the evolution of thrombus-laden
AAAs that require continued investigation:
(i) Structurally motivated stress-strain relations—quantify
the nonlinear heterogeneous mechanical properties of
both the ILT and aneurysmal wall, preferably including
constituent specific correlations with histological char-
acteristics as a lesion evolves.
(ii) Thrombus deposition and evolution—identify criteria
that govern the initial and subsequent hemodynamically
influenced deposition of thrombus and its evolving prop-
erties, including its compressibility, attachment to the
wall, and continual renewal of the luminal layer but deg-
radation of underlying layers.
(iii) Biomolecular kinetics—identify key biomolecules, or
classes of biomolecules, that affect the G&R of the
ILT and AAA, including cell sources and relevant rates
of production, activation, inhibition, convection/diffu-
sion, and degradation.
(iv) Failure/rupture—quantify regionally the strength of the
ILT and aneurysmal wall and formulate models of fail-
ure that include the propagation of dissections or
fissures.
Fig. 8 Schema of some of the primary effectors governing the evolution of the
mechanics of both the ILT and aneurysmal wall. Solid black arrow – “increases
the amount/activity,” dotted black line—“degrades,” dashed gray line—“modulates
the effect.” (ILT: intraluminal thrombus, SMC: smooth muscle cell, FB: fibroblast,
WBC: white blood cell, RBC: red blood cell).
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Experimental advances and constitutive formulations along
these lines would significantly enhance our ability to develop
fluid-solid-growth (FSG) models that will bring us closer to
understanding and predicting the complex, biochemomechanical
effects of ILT on AAA progression, with the ultimate goal of
improving patient-specific risk stratification and clinical outcome.
Appreciating early on the underlying complexity of this serious
vascular disease is essential, however, to establish the scope of the
problem and to coordinate effectively future experimental and
computational investigations.
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